Panacur SC 2.5% Oral Suspension

Summary of Product characteristics

                                Revised: 08 June 2010
AN: 00345/2010
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT FOLLOWED BY THE
STRENGTH AND THE PHARMACEUTICAL FORM
Panacur SC 2.5% Oral suspension
2.
NAME AND PROPORTION OF EACH ACTIVE SUBSTANCE, AND OF ANY
EXCIPIENT, IF KNOWLEDGE OF THE EXCIPIENT IS NEEDED FOR SAFETY
REASONS
Active substances
%w/v
Fenbendazole
2.500
Other substances
Cobalt sulphate heptahydrate
0.450*
Sodium selenate decahydrate 40% w/w solution
0.475**
Sodium methylhydroxybenzoate
0.200
Sodium propylhydroxybenzoate
0.020
* equivalent to 0.94mg/ml elemental cobalt
** equivalent to 0.4mg/ml elemental selenium
3.
PHARMACEUTICAL FORM
Oral suspension
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Sheep
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
A broad spectrum anthelmintic for the treatment of sheep infected with
benzimidazole susceptible mature and developing immature forms of
nematodes of the gastro-intestinal and respiratory tracts. The product
also has
an ovicidal effect on nematode eggs.
Sheep: For the treatment of sheep infected with benzimidazole
susceptible:
Ostertagia spp.
Haemonchus spp.
Trichostrongylus spp.
Nematodirus spp.
Cooperia spp.
Oesophagostomum spp.
Chabertia spp.
Bunostomum spp.
Strongyloides spp.
_Dictyocaulus filaria_
Panacur is usually effective against Moniezia spp. of tapeworm and may
have
useful but variable efficacy against Trichuris spp.
Page 1 of 6
Revised: 08 June 2010
AN: 00345/2010
The selenium and cobalt in this product are trace elements of use as
nutritional
supplements.
4.3
CONTRA-INDICATIONS
Do not use in species other than sheep.
4.4
SPECIAL WARNING FOR EACH TARGET SPECIES
Care should be taken to avoid the following practices because they
increase
the risk of development of resistance and could ultimately result in
ineffective
therapy:

Too frequent and repeated use of anthelmintics from the same class,
over an extended period of time.

Under dosing, which may be due to underestimation of body weight,
misadministration of the product, or lack
                                
                                Read the complete document